| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 02/27/1997 | WO1997006828A1 Method for treatment of cancer and infectious diseases and compositions useful in same |
| 02/27/1997 | WO1997006821A1 Heat shock protein-based vaccines and immunotherapies |
| 02/27/1997 | WO1997006818A1 Pharmaceutical compositions for competitively inhibiting the binding of a retrovirus to the ifn-receptor and means for diagnosis of an hiv infection |
| 02/27/1997 | WO1997006791A1 METHODS AND COMPOSITIONS USEFUL FOR INHIBITION OF αvβ5 MEDIATED ANGIOGENESIS |
| 02/27/1997 | WO1997006685A1 Method for treatment of cancer and infectious diseases and compositions useful in same |
| 02/27/1997 | WO1997006669A1 Regulation of plant development and physiology through plasmodesmatal macromolecular transport of proteins and oligonucleotides |
| 02/27/1997 | WO1997004115A3 Method for producing haemin proteins using plant cells, resulting proteins and products containing same |
| 02/27/1997 | WO1997004098A3 MODIFIED HUMAN CHORIONIC (β-hCG) PROTEINS AND THEIR MEDICAL USE |
| 02/27/1997 | WO1997004003A3 Process for protein refolding by means of buffer exchange using a continuous stationary phase capable of separating proteins from salts |
| 02/27/1997 | WO1997003188A3 Use of mp52 or mp121 for treating and preventing diseases of the nervous system |
| 02/27/1997 | WO1997001579A3 Somatostatin peptides |
| 02/27/1997 | WO1997000965A3 A lipidic vector for nucleic acid delivery |
| 02/27/1997 | WO1996040885A3 β-SECRETASE, ANTIBODIES TO β-SECRETASE, AND ASSAYS FOR DETECTING β-SECRETASE INHIBITION |
| 02/27/1997 | DE19629166A1 Amplification primer for animal cytochrome b gene |
| 02/27/1997 | DE19531033A1 Antikörper gegen an Oberflächen von Carcinom-Zellen außerhalb von Desmosomen exponierte Epitope desmosomaler Cadherine Antibodies against at surfaces of carcinoma cells outside exposed epitopes of desmosomal cadherins of desmosomes |
| 02/27/1997 | CA2230195A1 A method to increase the density of antigen on antigen presenting cells |
| 02/27/1997 | CA2230051A1 Deuteriated substances |
| 02/27/1997 | CA2229938A1 Methods of assessing mhc class i expression and proteins capable of modulating class i expression |
| 02/27/1997 | CA2229847A1 High efficiency retroviral packaging system |
| 02/27/1997 | CA2229605A1 Genes and proteins controlling cholesterol synthesis |
| 02/27/1997 | CA2229595A1 Method for treatment of cancer and infectious diseases and compositions useful in same |
| 02/27/1997 | CA2229557A1 Binding of osteogenic protein-i (op-1) and analogs thereof to the cell surface receptor alk-1 and analogs thereof |
| 02/27/1997 | CA2229543A1 Heat shock protein-based vaccines and immunotherapies |
| 02/27/1997 | CA2229540A1 Epitope tagging system |
| 02/27/1997 | CA2229287A1 Regulation of cellular functions by ectopic expression of non-endogenous cell signalling receptors |
| 02/27/1997 | CA2229208A1 Dna sequences and secreted proteins encoded thereby |
| 02/27/1997 | CA2229168A1 Methods and materials for producing pathogen-resistant plants |
| 02/27/1997 | CA2229143A1 Reagents and methods useful for controlling the translation of hepatitis gbv proteins |
| 02/27/1997 | CA2229126A1 Opioid antagonists and methods of their use |
| 02/27/1997 | CA2228765A1 Pharmaceutical compositions for competitively inhibiting the binding of a retrovirus to the ifn-receptor and means for diagnosis of an hiv infection |
| 02/27/1997 | CA2227795A1 Allergen-xcd32 fusion proteins |
| 02/27/1997 | CA2227174A1 Traf inhibitors |
| 02/26/1997 | EP0759474A2 A regulatory factor involved in expression of nitrilase gene, and its gene |
| 02/26/1997 | EP0759473A1 Deleted Lysostaphingene of Staphylococcus simulans |
| 02/26/1997 | EP0759470A2 Gene encoding endoglycoceramidase activator |
| 02/26/1997 | EP0759469A1 Bacteriocin |
| 02/26/1997 | EP0759468A1 Feline interleukin-4 |
| 02/26/1997 | EP0759467A2 Hepatocyte growth factor activator inhibitor |
| 02/26/1997 | EP0759466A2 Low binding affinity interleukin-12 beta receptors |
| 02/26/1997 | EP0759465A1 Gene imparting flocculability to yeast and gene product |
| 02/26/1997 | EP0759441A2 Methods of treating neuropeptide Y-associated conditions |
| 02/26/1997 | EP0759170A1 Uses of green fluorescent protein |
| 02/26/1997 | EP0759090A1 Interaction of proteins involved in a cell death pathway |
| 02/26/1997 | EP0759086A1 Method of introducing pathogen resistance in plants |
| 02/26/1997 | EP0759085A1 Chimeric genes comprising a fungus-responsive element |
| 02/26/1997 | EP0759083A1 Methods of inducing gene expression by ionizing radiation |
| 02/26/1997 | EP0759082A1 Dna construct for effecting homologous recombination and uses thereof |
| 02/26/1997 | EP0759078A1 Genes for the synthesis of antipathogenic substances |
| 02/26/1997 | EP0759077A1 Lanthionine-containing antimicrobial compound |
| 02/26/1997 | EP0759076A1 GENES REGULATING THE RESPONSE OF $i(ZEA MAYS) TO WATER DEFICIT |
| 02/26/1997 | EP0759075A1 Apoptosis regulating gene |
| 02/26/1997 | EP0759074A1 Stabilizing solutions for proteins and peptides |
| 02/26/1997 | EP0759072A1 Poxvirus-canine distemper virus (cdv) recombinants and compositions and methods employing the recombinants |
| 02/26/1997 | EP0759069A1 Beta taipoxin as a cell growth factor and method |
| 02/26/1997 | EP0759068A1 $i(RPS2) GENE AND USES THEREOF |
| 02/26/1997 | EP0759067A1 Transforming growth factor alpha h1 |
| 02/26/1997 | EP0759037A1 Antigen/antibody specificity exchanger |
| 02/26/1997 | EP0759036A1 Immunointeractive molecules-i |
| 02/26/1997 | EP0759035A1 Methods for controlling t lymphocyte mediated immune responses |
| 02/26/1997 | EP0759034A1 Peptides for diagnostics and therapeutics |
| 02/26/1997 | EP0759033A1 CLONING OF NON-IgA Fc BINDING FORMS OF THE GROUP B STREPTOCOCCAL BETA ANTIGENS |
| 02/26/1997 | EP0759032A1 Isolated, mage-3 derived peptides which complex with hla-a2 molecules and uses thereof |
| 02/26/1997 | EP0759029A1 Modified milk growth factor |
| 02/26/1997 | EP0759028A1 Method of detecting prions in a sample and transgenic animal used for same |
| 02/26/1997 | EP0758906A1 Pegylation reagents and compounds formed therewith |
| 02/26/1997 | EP0758905A1 Pharmaceutical compositions comprising hirudin |
| 02/26/1997 | EP0758904A1 Methods and compositions for the treatment of glomerulonephritis and other inflammatory diseases |
| 02/26/1997 | EP0758903A1 Cryoprecipitated native fibrinogen concentrates |
| 02/26/1997 | EP0758902A1 Compositions and treatment for multiple sclerosis |
| 02/26/1997 | EP0758898A1 Activin antagonists as novel contraceptives |
| 02/26/1997 | EP0758841A1 Cotton modification using ovary-tissue transcriptional factors |
| 02/26/1997 | EP0726911A4 Treatment of immunologic and hematologic disorders with igfbp alone or complexed with igf |
| 02/26/1997 | EP0702558A4 Novel opioid peptide inhibitors |
| 02/26/1997 | EP0659045A4 Genetically engineered mice containing alterations in the genes encoding retinoic acid receptor proteins. |
| 02/26/1997 | EP0656059A4 Purified chitinases and use thereof. |
| 02/26/1997 | EP0635025A4 Process for preparing modified proteins. |
| 02/26/1997 | EP0596887A4 Genetically engineered mice containing alterations in the mhc class ii genes. |
| 02/26/1997 | EP0570554A4 Monoclonal antibody and antibody components elicited to a polypeptide antigen ground state |
| 02/26/1997 | EP0552267B1 Engineered bacteriophages and vaccines containing them |
| 02/26/1997 | EP0541753B1 NOVEL HYBRID, SOLUBLE AND UNCLEAVED gp160 VARIANT |
| 02/26/1997 | EP0519976B1 Neutrophil stimulating peptides |
| 02/26/1997 | EP0437537B1 Bacterial detection by phage transduction of detectable phenotype |
| 02/26/1997 | CN1143978A Antimicrobial proteins from aralia and impatiens |
| 02/26/1997 | CN1143969A Compositions and methods using unbound mpl receptor for stimulating platelet production |
| 02/26/1997 | CN1143968A Peptides inhibiting release of pepsine |
| 02/26/1997 | CN1143967A Method for variation of chromatin condensation |
| 02/26/1997 | CN1143894A Macrophage inflammatory proteins-3,-4 and -1 r |
| 02/26/1997 | CN1034123C Calcium channel blocking polypeptides from filistate hibernalis |
| 02/25/1997 | US5606086 Heat resistant carbonate-and/or bicarbonate-iron-lactoferrin complex |
| 02/25/1997 | US5606047 Includes polynucleotide duplexes that have significant binding activity for lupus antibodies |
| 02/25/1997 | US5606044 Using nucleic acid probes |
| 02/25/1997 | US5606043 Methods for the diagnosis of glaucoma |
| 02/25/1997 | US5606032 Extraction of vertebrate brain material to obtain protein; chromatographic purification |
| 02/25/1997 | US5606031 Expressing gene coding for neurotrophic factor in bacteria, solubilizing, sulfonylating, isolating and purifying by anion exchange chromatography, allowing to refold, purifying by cation exchange chromatography |
| 02/25/1997 | US5606030 Coconjugates of OMPC, HIV related peptides and anionic moieties |
| 02/25/1997 | US5606029 Gene for a growth factor and its cDNA and protein |
| 02/25/1997 | US5606028 Anchimeric radiometal chelating compounds |
| 02/25/1997 | US5606027 Antibodies to a neutrophil chemotactic protein |
| 02/25/1997 | US5606025 Hemoglobin-enzyme complexes |
| 02/25/1997 | US5606024 Canine G-CSF polypeptides and pharmaceutical compositions comprising same |